title: [A new prospective vaccine against tick-borne encephalitis].
authors.forename: M P
authors.initials: MP
authors.lastname: Chumakov
authors.forename: S G
authors.initials: SG
authors.lastname: Rubin
authors.forename: I V
authors.initials: IV
authors.lastname: Semashko
authors.forename: A S
authors.initials: AS
authors.lastname: Karavanov
authors.forename: L I
authors.initials: LI
authors.lastname: Avdeeva
authors.forename: A V
authors.initials: AV
authors.lastname: Gagarina
authors.forename: A S
authors.initials: AS
authors.lastname: Gambarian
authors.forename: M N
authors.initials: MN
authors.lastname: Matrosovich
authors.forename: L I
authors.initials: LI
authors.lastname: Mart'ianova
authors.forename: L L
authors.initials: LL
authors.lastname: Mironova
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D004306:Dose-Response Relationship, Immunologic; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004669:Encephalitis Viruses, Tick-Borne / Q000276:immunology*; D004675:Encephalitis, Tick-Borne / Q000517:prevention & control*; D006801:Humans; D007114:Immunization; D051379:Mice; D013997:Time Factors; D014462:Ultrafiltration; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology / Q000302:isolation & purification; D014765:Viral Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology* / Q000302:isolation & purification; D014776:Virus Cultivation / Q000379:methods
chemical_list: D000914:Antibodies, Viral; D015164:Vaccines, Inactivated; D014765:Viral Vaccines
vernacular_title: Novaia perspektivnaia vaktsina protiv kleshchevogo éntsefalita.